Myungjin Haloperidol 3 mg

Adult dose

Schizophrenia, manic episodes associated with bipolar I disorder, symptoms of psychotic disorders, Tourette syndrome (Gilles de la Tourette's syndrome): The initial dose of haloperidol is 1-15㎎ daily, administered orally in 2-3 divided doses (up to 100㎎ may be administered in severe cases). Once a therapeutic response is achieved, gradually reduce the dose to the lowest effective maintenance dose. Adjust the dose as appropriate according to age and symptoms. Elderly and debilitated patients should receive an initial dose of haloperidol of 1-6mg daily, administered orally in 2-3 divided doses.

Child dose

14 years and older: The initial dose of haloperidol is 1-15㎎ daily, administered orally in 2-3 divided doses (up to 100㎎ may be administered in severe cases). Once a therapeutic response is achieved, gradually reduce the dose to the lowest effective maintenance dose.

This medication may increase the risk of death in elderly patients with dementia-related psychotic symptoms, so caution is needed. There may be an increased risk of cerebrovascular disease, so it should be used with particular caution in patients with stroke risk factors. Since there is a possibility of venous thrombosis, risk factors for thrombosis should be assessed and preventive measures undertaken before using this drug. This drug should not be used in patients who are allergic to it or similar medications, are in a coma or have alcohol dependence, have severe heart failure, and in patients with Parkinson’s disease, among others. In patients with impaired liver or kidney function, a history of cardiovascular disease or seizure disorders, and in the elderly, administration should be cautious, and their condition should be closely monitored during treatment. Cardiac side effects such as QT interval prolongation, arrhythmias, and changes in blood pressure can occur, so the cardiac status should be monitored periodically. Severe side effects such as neuroleptic malignant syndrome can occur, so physicians should be notified immediately if symptoms like fever, muscle rigidity, or altered consciousness appear. Movement disorders like extrapyramidal symptoms may occur, and irreversible movement disorders may appear with long-term use, requiring cessation of administration upon symptom occurrence. This medication may cause various side effects such as liver dysfunction, visual disturbances, allergic reactions, blood disorders, gastrointestinal symptoms, and endocrine disorders, so regular testing is necessary. Pregnant women or those who may become pregnant, and nursing mothers should not use this medication, and caution is required as it may also affect newborns. This medication can interact with several other drugs, so if there are concomitant medications, healthcare providers must be informed, and the risks of side effects due to changes in drug levels must be managed. Drowsiness or decreased concentration may occur, so driving or operating dangerous machinery should be avoided, and sudden cessation may cause withdrawal symptoms, so tapering should be undertaken. In case of overdose, severe side effects may occur, requiring immediate emergency treatment, and there is no specific antidote, so treatment based on symptoms is important.

Increased mortality rate, increased risk of cerebrovascular disease, venous thrombosis, abnormal electrocardiogram, hypotension, hypertension, tachycardia, ventricular tachycardia, thromboembolism, motor paralysis, muscle rigidity, dysphagia, dehydration, fever, leukocytosis, elevated serum CPK, myoglobinuria, renal impairment, altered consciousness, respiratory distress, circulatory collapse, symptoms of dehydration, acute renal failure, acute dystonia, oculomotor seizures, torticollis, trismus, Parkinsonian rigidity, tremor, akinesia, inability to sit upright, akinetic motor disorders, hepatitis, jaundice, liver dysfunction, retinitis, cataract, accommodative dysfunction of the eye, blurred vision, corneal opacity, lens opacity, corneal pigmentation, edema, erythema, urticaria, exfoliative dermatitis, photosensitivity, anaphylactic reaction, anemia, leukocytosis, leukopenia, erythrocytopenia, agranulocytosis, loss of appetite, nausea, vomiting, constipation, diarrhea, intestinal paralysis, paralytic ileus, hyperprolactinemia, gynecomastia, galactorrhea, menstrual irregularities, changes in libido, hyperglycemia, hypoglycemia, weight gain, weight loss, hyponatremia, hypooosmolarity, syndrome of inappropriate antidiuretic hormone secretion, bronchospasm, laryngeal spasm, respiratory distress, insomnia, anxiety, drowsiness, dizziness, headache, cephalalgia, anxiety, depression, hallucinations, agitation, thirst, nasal congestion, malaise, urinary retention, fever, sweating, flushing, hypothermia

This medication may be sensitive to light, so it should be stored in a light-resistant container, and kept in a sealed container to prevent air exposure.

Appearance

Pale yellow round tablet

Package unit

500 tablets/bottle